Current Evidence on Immunotherapy for Gestational Trophoblastic Neoplasia (GTN).
Giorgia MangiliGiulia SabettaRaffaella CioffiEmanuela RabaiottiGiorgio CandottiFrancesca PellaMassimo CandianiAlice BergaminiPublished in: Cancers (2022)
Anti-PD-1 or anti-PD-L1 might represent an important new treatment strategy for the management of chemoresistant/refractory GTN.